Cortagen Bioregulator: How It May Support Cognitive Health, Nerve Repair & Anti-Aging

Cortagen is a short synthetic peptide made of four amino acids: alanine, glutamic acid, aspartic acid and proline (Ala-Glu-Asp-Pro, or AEDP). It is one of the peptide bioregulators developed by Vladimir Khavinson’s group in St Petersburg, Russia, and it is aimed at the brain and nervous system.

It is promoted for cognitive health, nerve repair and anti-aging. The evidence behind those claims is small and preclinical: a handful of Russian studies in rats, mice and cells, most of them from the group that developed the peptide. There are no controlled human trials, and Cortagen is not an approved medicine.

This guide covers what Cortagen is, how it is thought to work, what the studies actually found, the doses people report and what is still unknown about safety.

What Is Cortagen?

Cortagen is a peptide bioregulator: a short synthetic tetrapeptide with the sequence Ala-Glu-Asp-Pro. It belongs to the same family of Khavinson peptides as Epitalon, Vilon, Cardiogen and Prostamax. The Cortagen compound profile gives a quick summary.

Khavinson’s group designed it from the amino acid makeup of Cortexin, a peptide extract from animal brain cortex that is registered as a medicine in Russia. Cortagen is also close to Epitalon (Ala-Glu-Asp-Gly): the two differ only in their last amino acid. Small as that difference looks, results for one peptide do not carry over to the other.

The theory behind the whole group is that each short peptide acts on one tissue by adjusting which genes are switched on. For Cortagen, the intended targets are the brain and nerves. Almost all of the research comes from Khavinson’s group and its collaborators, much of it published in Russian journals, and independent confirmation is limited.

Cortagen vs Cortexin

The two are related but not interchangeable. Cortexin is the older animal-derived product; Cortagen is the lab-made peptide based on it.

How Cortagen Is Thought to Work

Khavinson’s group proposes that short peptides like Cortagen work inside cells, at the level of DNA and gene expression, rather than through a classic receptor. For Cortagen, the proposed targets in neurons and glial cells (the support cells of the nervous system) are genes involved in:

• Cell survival: proteins that protect neurons from programmed cell death (apoptosis).
• Plasticity and repair: the growth and repair of connections between nerve cells.
• Inflammation: signals such as cytokines that drive inflammation in nerve tissue.
• Energy and oxidative stress: how cells produce energy and cope with oxidative damage.

These are proposed mechanisms, not effects measured in people. Whether injected Cortagen reaches the brain intact, how long it stays active and whether it behaves the same way in humans has not been tested in human studies. The older claims that it “rewires” or “reprograms” the brain, or treats the root causes of neurological disease, go well beyond the evidence.

What the Research Shows

The published work on Cortagen is small: studies in rats with nerve injury, studies in mice and lab work on cells. None of the findings below has been confirmed in controlled human trials.

Peripheral Nerve Regeneration (Rat Data)

In rat experiments on injured peripheral nerves, Cortagen injections were reported to increase nerve fiber regrowth and speed recovery compared with untreated animals. This is the main finding behind the “nerve repair” claim.

Rat nerve injury models are useful but limited. The injuries are made under controlled conditions, while nerve damage in people, from accidents, surgery, diabetes or other causes, is far more varied. A result in rats is a reason to run human trials, not evidence that Cortagen helps people with nerve damage or neuropathy.

Gene Activity in the Heart (Mouse Data)

In a microarray study, which measures the activity of thousands of genes at once, Cortagen changed the activity of more than 100 genes in mouse heart tissue. The authors read this as a sign that the peptide regulates genes beyond the brain.

A change in gene activity is not the same as a health benefit. The study measured gene activity, not heart function, so it does not show that Cortagen protects the heart. The heart-targeted peptide in this family is Cardiogen, which is a different compound.

Behavior, Stress and Immune Signals (Mouse Data)

A mouse study comparing Cortagen with Cortexin looked at locomotor activity and anxiety-related behavior. The effects depended on the dose: at the dose that worked best, the mice moved more without signs of anxiety, while other doses were linked to anxiety-like behavior.

This is a behavior test in mice. It does not show better memory, focus, mood or stress resilience in people, and the older claim that Cortagen normalizes the stress-hormone (HPA) axis and cortisol has not been shown in humans. Russian rodent and cell studies have also reported changes in interleukin-2 (IL-2), an immune signal, after Cortagen; what that means for inflammation in the human brain is unknown.

Chromatin and Aging (Cell Data)

The anti-aging label comes from lab work in which Khavinson-family peptides were reported to loosen tightly packed chromatin (heterochromatin), the form of DNA in which genes are mostly switched off, in cells from older people. The authors read this as reactivating genes that are silenced with age.

These are findings in cells in a dish. They do not show that Cortagen slows brain aging, protects memory or extends life in people. The older claims that it lowers oxidative damage in the brain and blood, or protects hearing during cisplatin chemotherapy, have no human data behind them.

What the Evidence Does and Doesn’t Show

Cortagen Dosage: What Is Commonly Reported

No human dose has been established in clinical trials. The figures below are the protocol listed in vendor descriptions and repeated in user reports, in the short-course pattern typical of injectable bioregulators. They are shown for information, not as a recommendation.

Doses used in mouse and rat studies cannot simply be scaled up to people, and the actual content and purity of research-grade vials vary between suppliers. Anyone considering Cortagen should talk to a doctor first, especially with a neurological condition or when taking other medicines.

Stacking With Other Bioregulators

Users often pair Cortagen with Epitalon, a synthetic pineal peptide studied for its effects on aging, and Thymalin, a thymus peptide extract used in Russia as an immune modulator. The idea is to cover the brain, the pineal gland and the immune system in one course.

No study has tested these combinations, so their combined effects and risks are unknown. Each peptide adds its own unknowns, and stacking makes it harder to tell what, if anything, is having an effect.

Side Effects & Safety

There are no controlled human trials of Cortagen, so its safety in people is unknown. The published animal studies reported no major adverse effects in the animals tested, but they were small and designed to measure nerve, gene and behavior effects, not to detect side effects in humans.

Reported Side Effects (Anecdotal)

• Injection site: Redness, slight swelling or discomfort, as with any subcutaneous injection.
• Short-lived symptoms: Some users describe mild tiredness after dosing. These are unverified reports, not study results.
• Anxiety or restlessness: Not documented in people, but in the mouse study some doses were linked to anxiety-like behavior.
• Allergic reactions: Possible with any peptide product; how often they occur with Cortagen is unknown.

Product Quality

Research-grade peptides are not made to drug standards. Wrong dosing, impurities, contamination or a vial that contains little or no Cortagen are real risks with any unregulated product.

Medical Oversight

• Get symptoms diagnosed: Memory problems, brain fog, numbness, tingling and nerve pain have many causes, including vitamin B12 deficiency, diabetes, thyroid problems, poor sleep and depression. Many of them are treatable.
• Keep prescribed treatment: Cortagen has not been shown to work in people. Never stop prescribed medicine to try it.
• Seek emergency care for sudden weakness or numbness on one side of the body, trouble speaking, sudden confusion or a sudden severe headache. These can be signs of a stroke.

Long-Term & Regulatory Considerations

• No long-term data: Nothing is known about the effects of repeated courses over months or years.
• Not FDA-approved: Cortagen is sold as a research chemical, labeled not for human use. All human use is unregulated.

Where to Buy Cortagen?

Cortagen is sold only as a research chemical. Quality varies widely between suppliers, so the first thing to ask for is a recent third-party certificate of analysis (COA) for the exact batch, with identity and purity testing. Our guide on how to read a peptide COA explains what to check.

SwissChems is the research-peptide supplier featured in our other bioregulator guides and has sold Cortagen in 20 mg vials. Prices change, so check current availability, the price and the batch COA on the supplier’s site before buying anything.

SwissChems Contents6 sections01What Is SwissChems?02Product Range03Top 3 Featured Products04Why It Gets Attention From Fitness Researchers05Testing, Documentation & Regulatory History06Frequently Asked Questions SwissChems is an online research-compound supplier covering SARMs,…

9.2Excellent

Visit SwissChemsBRAWN1010% OFFCopy

Pros

• Exceptional purity & testing (≥98%)
• Pharmaceutical-style packaging for stability
• Broad catalog across peptides & nootropics
• Strong reputation & consistency across years

Cons

• Some items frequently out of stock due to high demand
• Limited long-term data for some compounds